As shown in Figure 6C, D, there were no significant differences on the overall survival (OS) and recurrence free survival (RFS) between the high levels of NOTCH1 and the low levels of NOTCH1 in ESCC patients. This evidence concerns the gene NOTCH1 and esophageal squamous cell carcinoma.